Page 2 - Mark Klempner News Today

Relief for Lyme disease in humans may be on the way A new vaccine and shot are both in clinical trials; one is targeted for release in 2024 FacebookTwitterEmail The COVID-19 pandemic boosted the national conversation surrounding vaccines, which is helpful to those who have been working on a medicinal shot and vaccine to prevent Lyme disease.Courtney Hale/Getty Images At a time when all the talk seems to be about vaccinations for COVID-19, new chatter is building around a new vaccine and shot ...

As people weary of being cooped up during a pandemic winter look forward to a summer outside, residents across the northeastern United States are once again confronted with a familiar virulent pathogen lurking in the woods and fields. Unlike coronavirus, however, this dangerous microorganism doesn’t float through the air—it enters the body through the bite of a tick. Lyme disease has been a constant scourge since it was identified five decades ago on the Connecticut coastline, before spread...

WHYY By Artists Steve Donegan (center) and Syd Carpenter (right) created the hugel mound project, La Cresta, with the Woodmere Museum. (Peter Crimmins/WHYY) The Woodmere Museum’s stone Victorian mansion has been a landmark in the Chestnut Hill  neighborhood for 80 years, but few know what lies behind it. The museum is on a 6-acre estate whose back half slopes down toward the Morris Arboretum. Until relatively recently, that rear acreage has been largely ignored. “I’ve been living here in...

Sorry, but the video you are requesting is unavailable at this time, or unplayable on your platform! Melissa Rosales, NET News April 7, 2021 - 6:27am About 500,000 Americans are diagnosed with Lyme disease each year. A Boston-based company is developing a shot that fights against the most common insect-borne disease in the country. Phase one human trials for Lyme PrEP are ongoing in Nebraska. Dr. Scott Rasmussen is the principal investigator at Celerion in Lincoln, a contract research organizat...

Here’s how a seasonal shot may prevent Lyme disease Updated Mar 04, 2021; STATEN ISLAND, N.Y. — A new seasonal shot to prevent Lyme disease could be available in 2023, according to researchers at MassBiologics, a nonprofit unit of the University of Massachusetts Medical School, Worchester. Researchers are starting the first human clinical trial of the shot, called Lyme PrEP, according to news releases from the University of Massachusetts Medical School Communications. The pre-exposure prop...

It could be available by 2023.

Lyme PrEP, a seasonal shot to prevent Lyme disease developed by MassBiologics at UMass Medical School, has begun enrolling volunteers to evaluate the safety and pharmacology of the treatment.

Initial testing is likely to continue through 2021, to make sure the antibodies can last through an entire tick season.